{"title":"Malignant Melanoma Detection Using Ensemble Model and Improved BIRCH Clustering-Based Segmentation.","authors":"Pavithra G, Palanisamy C","doi":"10.1080/07357907.2025.2502052","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>The most deadly disease in skin cancers family is melanoma. The color resemblance among melanoma-affected and healthy areas pose significant challenges in early detection.</p><p><strong>Objective: </strong>An automated localization and segmentation of skin lesions at earlier stages remains challenging. To tackle these issues, a new method is proposed in this research for detecting malignant melanoma.</p><p><strong>Method: </strong>This proposed strategy comprises five stages namely augmentation, preprocessing, segmentation, feature extraction, and classification. Initially, data augmentation is performed, then median filtering and image enhancement are applied to input image during preprocessing. Subsequently, IBIRCH algorithm is employed for segmentation. Furthermore, color and shape features, statistical features and improved local texton XOR pattern are extracted. Finally, ensemble model (proposed Bi-LSTM, CNN and DBN) is proposed which receives features and intermediate score obtained from each model undergoes improved score level fusion and yields final classification output.</p><p><strong>Results: </strong>The proposed model is evaluated against traditional models and the suggested model achieved superior accuracy of 97.59% and 95.32% on datasets 1 and 2, respectively.</p><p><strong>Conclusion: </strong>The improved performance of proposed model not only outperforms traditional approaches but also paves way for reliable automated early-stage melanoma diagnosis and so reduces life risk of patients due to this early detection.</p>","PeriodicalId":9463,"journal":{"name":"Cancer Investigation","volume":" ","pages":"355-390"},"PeriodicalIF":1.8000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Cancer Investigation","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1080/07357907.2025.2502052","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/6/9 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: The most deadly disease in skin cancers family is melanoma. The color resemblance among melanoma-affected and healthy areas pose significant challenges in early detection.
Objective: An automated localization and segmentation of skin lesions at earlier stages remains challenging. To tackle these issues, a new method is proposed in this research for detecting malignant melanoma.
Method: This proposed strategy comprises five stages namely augmentation, preprocessing, segmentation, feature extraction, and classification. Initially, data augmentation is performed, then median filtering and image enhancement are applied to input image during preprocessing. Subsequently, IBIRCH algorithm is employed for segmentation. Furthermore, color and shape features, statistical features and improved local texton XOR pattern are extracted. Finally, ensemble model (proposed Bi-LSTM, CNN and DBN) is proposed which receives features and intermediate score obtained from each model undergoes improved score level fusion and yields final classification output.
Results: The proposed model is evaluated against traditional models and the suggested model achieved superior accuracy of 97.59% and 95.32% on datasets 1 and 2, respectively.
Conclusion: The improved performance of proposed model not only outperforms traditional approaches but also paves way for reliable automated early-stage melanoma diagnosis and so reduces life risk of patients due to this early detection.
期刊介绍:
Cancer Investigation is one of the most highly regarded and recognized journals in the field of basic and clinical oncology. It is designed to give physicians a comprehensive resource on the current state of progress in the cancer field as well as a broad background of reliable information necessary for effective decision making. In addition to presenting original papers of fundamental significance, it also publishes reviews, essays, specialized presentations of controversies, considerations of new technologies and their applications to specific laboratory problems, discussions of public issues, miniseries on major topics, new and experimental drugs and therapies, and an innovative letters to the editor section. One of the unique features of the journal is its departmentalized editorial sections reporting on more than 30 subject categories covering the broad spectrum of specialized areas that together comprise the field of oncology. Edited by leading physicians and research scientists, these sections make Cancer Investigation the prime resource for clinicians seeking to make sense of the sometimes-overwhelming amount of information available throughout the field. In addition to its peer-reviewed clinical research, the journal also features translational studies that bridge the gap between the laboratory and the clinic.